Live Breaking News & Updates on Heather Lynn Mcarthur

Stay updated with breaking news from Heather lynn mcarthur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr McArthur on Neoadjuvant Pembrolizumab Plus Chemotherapy in ER+/HER2– Breast Cancer

Heather Lynn McArthur, MD, MPH, discusses the primary results from the phase 3 KEYNOTE-756 study of neoadjuvant pembrolizumab plus chemotherapy in early-stage, high-risk, estrogen receptor–positive, HER2-negative breast cancer. ....

Heather Lynn Mcarthur , Department Of Internal Medicine , Breast Cancer Program , Clinical Breast Cancer Research , Ut Southwestern Medical Center , Oncology Division , Simmons Cancer Center , Internal Medicine , Medical Center , Komen Distinguished Chair , Ut Southwestern Haroldc Simmons Comprehensive Cancer Center , Onclive Tv , Breast Cancer ,

Dr McArthur on the Optimal Sequencing of Treatments in Metastatic TNBC

Heather Lynn McArthur, MD, MPH, discusses key factors considered in the optimal sequencing of first and second line treatment option in patients with advanced triple-negative breast cancer.
....

Heather Lynn Mcarthur , Simmons Cancer Center , Department Of Internal Medicine , Ut Southwestern Medical Center , Breast Cancer Program , Oncology Division , Internal Medicine , Medical Center , Ut Southwestern Haroldc Simmons Comprehensive Cancer Center , Onclive Tv , Breast Cancer , Triple Negative Breast Cancer , First Line , Second Line , Pd L1 Status , De Novo Metastatic Disease , Platinum Based Chemotherapy , Parp Inhibitors ,